Organon (XTER:7XP) Accounts Payable & Accrued Expense : €2,333 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Accounts Payable & Accrued Expense?

Organon's quarterly accounts payable & accrued expense increased from Sep. 2023 (€2,327 Mil) to Dec. 2023 (€2,668 Mil) but then declined from Dec. 2023 (€2,668 Mil) to Mar. 2024 (€2,333 Mil).

Organon's annual accounts payable & accrued expense increased from Dec. 2021 (€2,290 Mil) to Dec. 2022 (€2,364 Mil) and increased from Dec. 2022 (€2,364 Mil) to Dec. 2023 (€2,668 Mil).

Organon Accounts Payable & Accrued Expense Historical Data

The historical data trend for Organon's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Accounts Payable & Accrued Expense Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,176.30

991.33

2,290.38

2,363.78

2,667.55

Organon Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial														2,183.69	2,195.82	2,326.57	2,667.55	2,333.12

Organon Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Organon (XTER:7XP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (XTER:7XP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

OGN:USA OGN:Mexico 1OGN:Italy 0A9W:UK

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.

Organon (XTER:7XP) Headlines

No Headlines